Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ - Refiner Delek shares stabilize after issuing $400 million convertible bonds

BUZZ - Refiner Delek shares stabilize after issuing $400 million convertible bonds

路透社路透社2026/09/25 12:21
Show original

- ** Shares of refining company Delek US Holdings DK.N fell 0.6% in premarket trading on Friday to $66.50 after the company successfully completed a financing round

** The company announced late Thursday (link) that it has priced a $400 million private placement of convertible senior notes with a 0% coupon, due November 1, 2031

** The conversion price is set at $85.31, which is 27.5% higher than Thursday’s closing price of $66.91

** On Thursday, DK shares declined for the fifth consecutive trading day, closing down 7.4%, after the company (link) disclosed that the proceeds from the offering will be used for general purposes, including partial repayment of term loans

** The company plans to use part of the raised funds to enter into capped call transactions; the capped price of $117.09 represents a premium of about 75% over the latest closing price of the stock

** As of Thursday, the stock has risen nearly 126% so far this year. In comparison, the S&P 600 Oil, Gas & Consumable Fuels Index .SPSMCOIG rose 34%, and the S&P 1500 Oil, Gas Refining & Marketing Index .SPCOMENRM rose 123%

** According to London Stock Exchange Group (LSEG) data, the average rating from 13 analysts is “Buy”; the median target price is $72, up from $50 on June 25


(To serve non-native English speakers, Reuters provides automated translation of its reports into several other languages. Due to potential errors or the absence of required context in automated translation, Reuters does not guarantee the accuracy of the automated translation, which is provided purely for the convenience of readers. Reuters assumes no responsibility for any harm or losses that may result from using the automated translation feature.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Equinix (EQIX.US) chosen as the top stock for Citi’s data centers: AI integration accelerates in one year what took the cloud seven years, making interconnected networks the biggest winners

Citigroup maintains a "Buy" rating on Equinix and lists it as a top pick, expecting its recurring revenue to accelerate to 13% by 2027, with a target price of $1,320.

智通财经•2026/11/18 07:21
Equinix (EQIX.US) chosen as the top stock for Citi’s data centers: AI integration accelerates in one year what took the cloud seven years, making interconnected networks the biggest winners

Japan's 20-year government bond auction sees weak demand as bid-to-cover ratio drops sharply to 3.64, marking the lowest demand of the year

Japan's 20-year government bond auction saw weak demand, with the bid-to-cover ratio falling to 3.64 and the tail widening to its largest in a year. The market is concerned about fiscal budget issues and rising yields.

智通财经•2026/11/18 06:52
Japan's 20-year government bond auction sees weak demand as bid-to-cover ratio drops sharply to 3.64, marking the lowest demand of the year

Google-backed AI pharmaceutical company raises $5 billion in funding, doubling the previous round

The current funding round for Isomorphic Labs is co-led by top VCs including Sequoia Capital and Andreessen Horowitz. This round comes only six months after the previous $2.1 billion Series B, with the scale more than doubling. By 2026, total financing in the AI pharmaceutical sector has reached a record high of $23.2 billion, with Anthropic and OpenAI also entering the field.

华尔街见闻•2026/11/18 06:51